Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615000481572
ACTRN12615000481572
Completed
Phase 3

A prospective, double-blind, double-dummy, randomised controlled trial to compare pain relief from intravenous paracetamol and oral paracetamol in acute pain patients presenting to the Emergency Department

The Townsville Hospital and Health Service0 sites100 target enrollmentMay 15, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPainInjuries and Accidents - Other injuries and accidentsAnaesthesiology - Pain management

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pain
Sponsor
The Townsville Hospital and Health Service
Enrollment
100
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Townsville Hospital and Health Service

Eligibility Criteria

Inclusion Criteria

  • •Age greater than or equal to 18years
  • •Already has intravenous access or has a clinical condition indicating that intravenous access is required
  • •Have received at least one initial dose of morphine (either with Queensland Ambulance Service or in ED) with ongoing pain score \>40mm on the Visual Analogue Scale (VAS) at \> 5 minutes post administration of morphine or equivalent.

Exclusion Criteria

  • •Any state (e.g. intoxicated) or medical history (e.g. mental health disorder) impairing accurate pain assessment
  • •Known/suspected to have drug dependence
  • •Allergic to paracetamol
  • •Received or taken paracetamol in the last 6 hours
  • •Known or suspected Renal or hepatic insufficiency
  • •Currently enrolled in other clinical trials for the treatment of pain
  • •Unable to safely swallow oral medication

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A double-blind, double-dummy, prospective, randomized multiple-site study of oral Finafloxacin 300 mg b.i.d. versus oral Ciprofloxacin 250 mg b.i.d. in patients with lower uncomplicated UTI (uUTI) with a treatment duration of 3 days. - FLUTower uncomplicated Urinary Tract InfectionMedDRA version: 9.1Level: LLTClassification code 10046571Term: Urinary tract infection
EUCTR2007-007742-35-DEMerLion Pharmaceuticals GmbH48
Active, not recruiting
Not Applicable
This study aims to find out how effective and save Angocin Anti-Infekt N is in treatment of acute uncomplicated cystitis in contrast to standard antibiotics.Treatment of acute uncomplicated cystitisMedDRA version: 14.1Level: PTClassification code 10011781Term: CystitisSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2010-022096-54-DERepha GmbH
Not yet recruiting
Not Applicable
A Clinical Study to compare the Effects of Cilnidipine 10 mg Tablet versus Amlodipine 10 mg Tablet in Patients of Newly Diagnosed Hypertension.
CTRI/2022/04/042233Dr Amey Beedkar
Active, not recruiting
Not Applicable
A prospective, randomized, double-blind, double-dummy, placebo- and active controlled, multicenter study assessing the efficacy and safety of the combination BAY 60 4552 / vardenafil compared to vardenafil (20 mg) for the treatment of erectile dysfunction not sufficiently responsive to standard therapy with PDE5 inhibitors
EUCTR2010-020122-18-FIBayer HealthCare AG267
Completed
Phase 2
A prospective, randomized, double-blind, double-dummy, placebo- and active controlled, multicenter study assessing the efficacy and safety of the combination BAY 60 4552 / vardenafil compared to vardenafil (20 mg) for the treatment of erectile dysfunction not sufficiently responsive to standard therapy with PDE5 inhibitors
NL-OMON34486Bayer30